| Literature DB >> 19217924 |
Shintaro Ohgake1, Eiji Shimizu, Kenji Hashimoto, Naoe Okamura, Kaori Koike, Hiroyuki Koizumi, Mihisa Fujisaki, Nobuhisa Kanahara, Shingo Matsuda, Chihiro Sutoh, Daisuke Matsuzawa, Hisako Muramatsu, Takashi Muramatsu, Masaomi Iyo.
Abstract
Midkine is a 13-kDa retinoic acid-induced heparin-binding growth factor involved in various biological phenomena such as cell migration, neurogenesis, and tissue repair. We previously demonstrated that midkine-deficient (Mdk(-/-)) mice exhibited a delayed hippocampal development with impaired working memory and increased anxiety only at the age of 4 weeks. To assess whether midkine gene could play important roles in development and maintenance of central nervous system, we investigated biochemical and behavioral parameters in dopamine and glutamate neurotransmission of Mdk(-/-) mice. The Mdk(-/-) mice exhibited a hypodopaminergic state (i.e., decreased levels of dopamine and its receptors in the striatum) with no alterations of glutamatergic system (i.e., normal level of glutamate, glutamine, glycine, d-serine, l-serine, and NMDA receptors in the frontal cortex and hippocampus). We also found prepulse inhibition deficits reversed by clozapine and haloperidol in the Mdk(-/-) mice. Our results suggested that midkine deficiency may be related to neurochemical and behavioral dysfunctions in dopaminergic system.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19217924 DOI: 10.1016/j.pnpbp.2009.02.005
Source DB: PubMed Journal: Prog Neuropsychopharmacol Biol Psychiatry ISSN: 0278-5846 Impact factor: 5.067